Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study of FG-4592 to Correct Anemia in New Dialysis Patients

Trial Profile

Study of FG-4592 to Correct Anemia in New Dialysis Patients

Phase of Trial: Phase II

Latest Information Update: 01 Apr 2016

At a glance

  • Drugs Roxadustat (Primary) ; Iron
  • Indications Anaemia
  • Focus Therapeutic Use
  • Sponsors FibroGen
  • Most Recent Events

    • 13 Jun 2014 Last checked against ClinicalTrials.gov record.
    • 21 Apr 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top